Evidence map›Paper›PMID 25662956›Full record

ArticleExperimental biology and medicine (Maywood, N.J.)2015

Lung inflation with hydrogen during the cold ischemia phase decreases lung graft injury in rats.

Rongfang Liu, Xianhai Fang, Chao Meng, Jingchun Xing, Jinfeng Liu, Wanchao Yang, Wenzhi Li, Huacheng Zhou

Open access · greenAbstract read
In one paragraph

Article in Experimental biology and medicine (Maywood, N.J.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. [Curcumin alleviates septic lung injury in mice by inhibiting TXNIP/TRX-1/GPX4-mediated ferroptosis].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2024
    Article
  3. The Protective Role of Molecular Hydrogen in Ischemia/Reperfusion Injury.International journal of molecular sciences · 2024
    Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Molecular hydrogen is a promising therapeutic agent for pulmonary disease.Journal of Zhejiang University. Science. B · 2022
    Article
  10. Protective effects of molecular hydrogen on lung injury from lung transplantation.Experimental biology and medicine (Maywood, N.J.) · 2021
    Review
  11. Article
  12. Hydrogen: Potential Applications in Solid Organ Transplantation.Oxidative medicine and cellular longevity · 2021
    Review
  13. Article
  14. Review
  15. Review
  16. Hydrogen water alleviates obliterative airway disease in mice.General thoracic and cardiovascular surgery · 2020
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Rongfang LiuDepartment of Anesthesiology, The Second Affiliated Hospital, Harbin Medical University, Harbin 150081, China Hei Long Jiang Province Key Lab of Research on Anesthesiology and Critical Care Medicine, Harbin 150081, China.
Xianhai FangDepartment of Anesthesiology, The Second Affiliated Hospital, Harbin Medical University, Harbin 150081, China Hei Long Jiang Province Key Lab of Research on Anesthesiology and Critical Care Medicine, Harbin 150081, China.
Chao MengDepartment of Anesthesiology, The Second Affiliated Hospital, Harbin Medical University, Harbin 150081, China Hei Long Jiang Province Key Lab of Research on Anesthesiology and Critical Care Medicine, Harbin 150081, China.
Jingchun XingDepartment of Anesthesiology, The Second Affiliated Hospital, Harbin Medical University, Harbin 150081, China Hei Long Jiang Province Key Lab of Research on Anesthesiology and Critical Care Medicine, Harbin 150081, China.
Jinfeng LiuDepartment of Anesthesiology, The Second Affiliated Hospital, Harbin Medical University, Harbin 150081, China Hei Long Jiang Province Key Lab of Research on Anesthesiology and Critical Care Medicine, Harbin 150081, China.
Wanchao YangDepartment of Anesthesiology, The Second Affiliated Hospital, Harbin Medical University, Harbin 150081, China Hei Long Jiang Province Key Lab of Research on Anesthesiology and Critical Care Medicine, Harbin 150081, China.
Wenzhi LiDepartment of Anesthesiology, The Second Affiliated Hospital, Harbin Medical University, Harbin 150081, China Hei Long Jiang Province Key Lab of Research on Anesthesiology and Critical Care Medicine, Harbin 150081, China wenzhili9@126.com zhouhuacheng@163.com.
Huacheng ZhouDepartment of Anesthesiology, The Second Affiliated Hospital, Harbin Medical University, Harbin 150081, China Hei Long Jiang Province Key Lab of Research on Anesthesiology and Critical Care Medicine, Harbin 150081, China Department of Anesthesiology, The Fourth Affiliated Hospital, Harbin Medical University, Harbin 150081, China wenzhili9@126.com zhouhuacheng@163.com.
Harbin Medical University · CNSecond Affiliated Hospital of Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hydrogen has antioxidant and anti-inflammatory effects on lung ischemia-reperfusion injury when it is inhaled by donor or/and recipient. This study examined the effects of lung inflation with 3% hydrogen during the cold ischemia phase on lung graft function in rats. The donor lung was inflated with 3% hydrogen, 40% oxygen, and 57% nitrogen at 5 mL/kg, and the gas was replaced every 20 min during the cold ischemia phase for 2 h. In the control group, the donor lung was inflated with 40% oxygen and 60% nitrogen at 5 mL/kg. The recipient was euthanized 2 h after orthotropic lung transplantation. The hydrogen concentration in the donor lung during the cold ischemia phase was 1.99-3%. The oxygenation indices in the arterial blood and pulmonary vein blood were improved in the hydrogen group. The inflammation response indices, including lung W/D ratio, the myeloperoxidase activity in the grafts, and the levels of IL-8 and TNF-α in serum, were significantly lower in the hydrogen group (5.2 ± 0.8, 0.76 ± 0.32 U/g, 340 ± 84 pg/mL, and 405 ± 115 pg/mL, respectively) than those in the control group (6.5 ± 0.7, 1.1 ± 0.5 U/g, 443 ± 94 pg/mL, and 657 ± 96 pg/mL, respectively (P < 0.05), and the oxidative stress indices, including the superoxide dismutase activity and the level of malonaldehyde in lung grafts were improved after hydrogen application. Furthermore, the lung injury score determined by histopathology, the cell apoptotic index, and the caspase-3 protein expression in lung grafts were decreased after hydrogen treatment, and the static pressure-volume curve of lung graft was improved by hydrogen inflation. In conclusion, lung inflation with 3% hydrogen during the cold ischemia phase alleviated lung graft injury and improved graft function.

Indexed as

AnimalsAntioxidantsApoptosisCold IschemiaHydrogenLung ComplianceLung InjuryLung TransplantationMaleOrgan PreservationOxidative StressOxygenPrimary Graft DysfunctionRatsRats, Sprague-DawleyReperfusion InjuryAntioxidantsHydrogenOxygendonorHydrogenischemia reperfusion injurylung transplantation

Identifiers

PMID25662956
PMCPMC4935368
OpenAlexW2327870672

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.